GE HealthCare unveils Pristina Via to streamline technologist workflow and improve patient-centered breast care
GE HealthCare has unveiled the new Pristina Via mammography system at RSNA 2024, designed to enhance breast screening efficiency amid growing technologist shortages. The system features zero-click acquisition, faster image-to-image cycle time, and vendor-neutral prior image comparison.
Developed through extensive collaboration with technologists, including 250 interviews and observations, the system addresses the challenge of increasing vacancy rates (18% in 2024) while maintaining steady mammogram demand. Pristina Via offers the lowest radiation dose among major mammography systems and demonstrates 99% uptime under service contracts.
GE HealthCare ha presentato il nuovo sistema di mammografia Pristina Via al RSNA 2024, progettato per migliorare l'efficienza dello screening mammario in un contesto di crescente carenza di tecnologi. Il sistema offre acquisizione senza clic, un tempo di ciclo immagine-immagine più rapido e confronto di immagini precedenti indipendentemente dal fornitore.
Sviluppato attraverso una vasta collaborazione con tecnologi, che include 250 interviste e osservazioni, il sistema affronta la sfida dell'aumento dei tassi di vacanza (18% nel 2024) mantenendo una domanda costante di mammografie. Pristina Via offre la dose di radiazioni più bassa tra i principali sistemi di mammografia e dimostra un uptime del 99% sotto contratti di assistenza.
GE HealthCare ha presentado el nuevo sistema de mamografía Pristina Via en RSNA 2024, diseñado para mejorar la eficiencia de la detección del cáncer de mama en medio de la creciente escasez de tecnólogos. El sistema cuenta con adquisición sin clic, un ciclo de tiempo de imagen a imagen más rápido y comparación de imágenes anteriores sin importar el proveedor.
Desarrollado a través de una extensa colaboración con tecnólogos, incluyendo 250 entrevistas y observaciones, el sistema aborda el desafío del aumento de las tasas de vacantes (18% en 2024) mientras mantiene una demanda constante de mamografías. Pristina Via ofrece la dosis de radiación más baja entre los principales sistemas de mamografía y demuestra un tiempo de actividad del 99% bajo contratos de servicio.
GE HealthCare는 RSNA 2024에서 새로운 프리스티나 비아 유방촬영 시스템을 공개하였습니다. 이 시스템은 증가하고 있는 기술자의 부족 현상 속에서 유방스크리닝 효율을 향상시키기 위해 설계되었습니다. 시스템은 제로 클릭 촬영, 이미지 간 빠른 사이클 타임 및 공급업체에 관계없는 이전 이미지 비교 기능을 제공합니다.
250회의 인터뷰 및 관찰을 포함하여 기술자들과의 광범위한 협업을 통해 개발된 이 시스템은 2024년까지의Vacancy rate (18%) 증가 문제를 해결하면서도 안정적인 유방촬영 수요를 유지합니다. 프리스티나 비아는 주요 유방촬영 시스템 중 가장 낮은 방사선량을 제공하며, 서비스 계약 하에서 99%의 가동 시간을 보여줍니다.
GE HealthCare a dévoilé le nouveau système de mammographie Pristina Via lors du RSNA 2024, conçu pour améliorer l'efficacité du dépistage du cancer du sein face à une pénurie croissante de technologues. Le système dispose d'une acquisition sans clic, d'un temps de cycle image à image plus rapide et d'une comparaison d'images antérieures sans sujet de fournisseur.
Développé grâce à une vaste collaboration avec des technologues, incluant 250 entretiens et observations, le système répond au défi de l'augmentation des taux de vacance (18 % en 2024) tout en maintenant une demande stable de mammographies. Pristina Via offre la plus faible dose de radiation parmi les principaux systèmes de mammographie et démontre un temps de fonctionnement de 99 % dans le cadre de contrats de service.
GE HealthCare hat das neue Pristina Via Mammographiesystem auf der RSNA 2024 vorgestellt, das entwickelt wurde, um die Effizienz des Brustscreenings angesichts eines wachsenden Fachkräftemangels zu steigern. Das System bietet eine Null-Klick-Akquisition, schnellere Bild-zu-Bild-Zyklen und einen anbieterneutralen Vergleich von Vorabbildern.
Durch umfangreiche Zusammenarbeit mit Technologen, einschließlich 250 Interviews und Beobachtungen, wurde das System entwickelt, um die Herausforderung der steigenden Vakanzraten (18 % im Jahr 2024) zu bewältigen, während die Nachfrage nach Mammographien konstant bleibt. Pristina Via bietet die niedrigste Strahlendosis unter den wichtigsten Mammographiesystemen und weist eine Betriebszeit von 99 % unter Dienstverträgen auf.
- Advanced features enabling faster workflow with zero-click acquisition
- Up to 2x faster DBT image-to-image cycle time compared to competitors
- 99% system uptime rate under service contracts
- Lowest radiation dose among major mammography systems
- Backward compatibility providing future scalability
- None.
Insights
The launch of Pristina Via represents an incremental innovation rather than a transformative breakthrough in GE HealthCare's mammography portfolio. While the system offers workflow improvements like zero-click acquisition and faster image-to-image cycle times, these enhancements primarily address operational efficiency rather than introducing revolutionary diagnostic capabilities.
The key value proposition lies in addressing the significant technologist shortage (vacancy rates up from
The collaboration with SimonMed, a major imaging provider, provides validation but doesn't guarantee widespread adoption. While this launch strengthens GEHC's women's health portfolio, it's likely to have modest impact on financial performance.
- Amid technologist shortage, new mammography innovation was designed through intensive collaboration with technologists will help to streamline workflow and humanize care
Recent data from the American Society of Radiologic Technologists (ASRT) highlights a dramatic increase in technologist vacancy rates—from
As the company continues to evolve the patient-centric Senographe Pristina platform, Pristina Via brings advanced new features to help minimize repetitive tasks and streamline workflows so that mammography technologists can maintain their focus on providing quality and personalized care during the screening experience.
“At GE HealthCare, we are dedicated to addressing our customers’ needs by delivering solutions that enhance the experience for both patients and healthcare professionals,” said Jyoti Gupta, PhD – President & CEO for Women’s Health and X-ray at GE HealthCare. “Pristina Via represents a significant evolution in our patient focused Senographe Pristina platform which was designed by women for women. With the new in-room workflow, Pristina Via minimizes laborious tasks and provides technologists with the gift of time to prioritize what matters most: compassionate, patient-centered care.”
Setting a New Standard in Breast Imaging
The Pristina Via mammography system takes in-room workflow and patient comfort to the next level through:
- Zero-click acquisition functionality for faster, seamless workflows.
- No wait time between exposures, allowing technologists to operate at their own speed. Pristina Via DBT image-to-image cycle time is up to twice as fast as other mammography systems on the market.2
- Vendor-neutral prior image comparison, reducing time spent analyzing previous exams and enabling final assessments more efficiently.
- Lowest radiation dose used for all breast thicknesses amongst major mammography systems.3
The Pristina Via utilizes these advanced features to streamline technologists’ workflow and enable exceptional speed. Additionally, Pristina Via also features a future-focused, scalable platform with full backward compatibility to provide imaging centers access to the latest capabilities while also providing flexibility to support the evolving needs of their sites. Pristina Via is built on the Pristina platform which provides exceptional reliability. The Pristina platform is supported by GE HealthCare service contracts and warranty, under which the Pristina systems demonstrate a
Designed with Technologists in Mind
GE HealthCare developed the Pristina Via to build on its commitment of developing innovation to solve the challenges that patients and users face. The company performed almost 250 interviews and observations5 with mammography technologists, which revealed that technologists’ greatest challenge is keeping up with the rapid pace of modern medicine without sacrificing accuracy or patient-centered care.
“Simplifying, automating, and streamlining the mammography exam to improve in-room workflows is critical to driving patient compliance and access to screening,” said Dr. John Simon, CEO of SimonMed, one of the largest nationwide outpatient imaging providers serving hundreds of thousands of women with breast cancer screening and diagnostic services annually. “As a leading mammography provider in the country, we are actively investing in new technologies, workflows and AI innovation that improve clinical and operational outcomes. The enhancements offered by Pristina Via are part of our mission of making advanced technology accessible.”
“During our intensive collaboration with our end users in the design phase, we heard time and again that the technologist’s workday can feel like a race against the clock,” said Pooja Pathak, Vice President and General Manager for Global Mammography at GE HealthCare. “Pristina Via is our answer to this challenge. The system’s advanced features were engineered to automate processes and allow our users to give patients the attentive, quality care they deserve. I am thrilled that SimonMed our longtime customer, will be implementing this new technology as part of their mammography services.”
For more information on GE HealthCare’s women’s health technology at RSNA, including the company’s new collaboration with RadNet’s DeepHealth, please visit Booth 7330 at RSNA , the RSNA 2024 press kit or the RSNA 2024 events page.
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a
Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.
__________________________________ |
|
* Pristina Via is commercial name of Senographe Pristina. |
|
1 |
https://www.rsna.org/news/2024/october/radiologic-technologist-shortage |
2 |
Image to Image cycle time is the minimum waiting time by the System between two consecutive images. Measured with ACR phantoms for Pristina Via compared to claimed performance of competitor (Dimension 3D_ in Product Data Sheet from Jul-2024) |
3 |
Phantom measurements as of July 2024. Senographe Pristina with default value STD mode. Dose comparison based on NHS Breast Screening Programme equipment reports. https://medphys.royalsurrey.nhs.uk/nccpm/?s=technicalreports. |
4 |
1) Analysis of the 42543 Service requests on Pristina platform systems under Contract or Warranty from January 2022 to September 2024; 2) Since there is no “typical” hospital and many variables exist, i.e., hospital size, working days, working hours, there can be no guarantee that each Pristina system will achieve the same results. |
5 |
Opportunity Discovery & Product Strategy Proposal for GE Healthcare, Strategyn, May-September 2024. GE HealthCare Data on File. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20241126789290/en/
GE HealthCare Media Contact:
Linh Dinh
Communications Director
408.275.5682
Linh.Dinh@geheatlhcare.com
Source: GE HealthCare Technologies Inc.
FAQ
What are the key features of GE HealthCare's new Pristina Via mammography system (GEHC)?
How much faster is Pristina Via's DBT image cycle time compared to other systems (GEHC)?
What is the system uptime rate for GE HealthCare's Pristina Via (GEHC)?
What is the current technologist vacancy rate in 2024 that Pristina Via addresses (GEHC)?
